As such, obesity predisposes defective insulin signaling, lowering insulin sensitivity and trans-membranous glucose transport capacity, ultimately decreasing plasma-glucose removal. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.